Abstract
Background. Background. Hypertension refers to 9.5 million people between 18 and 79 years of age, which corresponds to 32% of the population. The disease significantly impedes the daily life of the limitations associated with the severity of symptoms, the treatment process and the factors that influence the quality of life. Objectives. Quality of life assessment of patients with hypertension and to investigate the factors that affect the results. Material and methods. The study was carried out among 70 patients (39 women and 31 men) from January to May 2014. The study used an analysis of medical records of patients and a questionnaire to assess the overall quality of life of the SF-36 (Short Form-36). Results. Examined correlations of individual groups of variables to measure physical component sumary (PCS), mental component sumary (MCS) and general QoL index: gender (PCS – p = 0.716; MCS – p = 0.698; QoL = 0.778), age (PCS – R = 0.64; p < 0.001; MCS – R = 0.36; p = 0.002; QoL – R = 0.58; p < 0.001), place of residence (PCS – p = 0.273; MCS – p = 0.767; p = 0.355; QoL – p = 0.355), education (PCS – R = -0.48; p < 0.001; MCS – R = -0.26; p = 0.032; QoL – R = -0.43; p < 0.001), employment status (PCS – p = 0.02; MCS – p = 0.072; QoL = 0.02), type of work performed (PCS – p = 0.911; MCS, p = 0.902; QoL – p = 0.976), social and living conditions (PCS – R = -0.24; p = 0.044; MCS – R = -0.27; p = 0.023; QoL – R = -0.25; p = 0.039), disease duration (PCS – R = 0.46; p = 0.005; MCS – R = 0.33; p = 0.056; QoL – R = 0.44; p = 0.008), conduct self-control (PCS – p = 0.127; MCS, p = 0.382; QoL – p = 0.113), the incidence of self-control (PCS – R = 0.31, p = 0.010; MCS – R = 0.22; p = 0.070; QoL – R = 0.32; p = 0.006), comorbidities (PCS – p < 0.001; MCS – p = 0.001; QoL – p < 0.001). Conclusions. Hypertension adversely affects the quality of life assessment. The quality of life is affected by: older age, higher education, professional status, social and living conditions, longer duration of the disease, the frequency of measurement of pressure, comorbidities.References
Julius S. Current trends in the treatment of hypertension: a mixed picture. Am J Hypertens 1997; 10: 300–305.
Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–1360.
Gajewska D, Ździeborska M, Harton A, i wsp. Ocena znajomości i przestrzegania zaleceń dietetycznych przez pacjentów z nadciśnieniem tętniczym pierwotnym. Probl Hig Epidemiol 2013; 4(2): 259.
Więczkowska H, Bryl W, Hoffmann K. Nadciśnienie tętnicze – choroba trudna i kosztowna. Forum Zab Metabol 2011; 2(2): 132–136.
Matschay A, Turostowska R. Ocena jakości współpracy lekarza i pacjenta w leczeniu nadciśnienia tętniczego wśród populacji kobiet i mężczyzn. Now Lek 2013; 82(4): 295–302.
Zygmuntowicz M, Olszanecka-Glinianowicz M, Chudek J. Jakość życia osób z nadciśnieniem tętniczym. Endokrynol Otyłość Zab Przem Materii 2011; 7(3): 179–185.
McHorney CA, Ware JE. Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–263.
Tylka J, Piotrowicz R. Kwestionariusz oceny jakości życia SF-36 – wersja polska. Kardiol Pol 2009; 67: 1166–1169.
Beto JA, Bansal VK. Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Am J Hypertens 1992; 5: 125–133.
Pokorna-Kałwak D, Muszyńska A, Mastalerz-Migas A, i wsp. Pacjent z nadciśnieniem tętniczym w wieku podeszłym – wpływ choroby i prowadzonego leczenia na samopoczucie chorego. Psychoger Pol 2008; 5(1): 37–46.
Klocek M, Kawecka-Jaszcz K. Jakość życia chorych z pierwotnym nadciśnieniem tętniczym. Część I: Wpływ czynników socjodemograficznych. Przegl Lek 2003; 60: 92–100.
Januszewicz W, Januszewicz A, Prejbisz A. Ważne badania w dziedzinie nadciśnienia tętniczego. Post Nauk Med 2009; 1: 50–54.
Zdziebło K, Maciejska J, Trela-Lech J. Wpływ czynników socjalno- -bytowych i zdrowotnych na poziom satysfakcji z życia ludzi w podeszłym wieku. Stud Med 2013; 29(4): 293–299.
Fogari R, Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drug Aging 2004; 21: 377–393.
Li W, Liu L, Puente JG, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens 2005; 23: 1667–1676.
Wang R, Zhao Y, He X, et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health 2009; 123: 534–539.